Global Next-Generation
Sequencing (NGS) Market Segmentation, By Technology (Whole Genome Sequencing
(WGS), Whole Exome Sequencing (WES), Targeted Sequencing {Gene Panels, Custom
Targeted Sequencing}, RNA Sequencing {Transcriptome Sequencing, Single-Cell RNA
Sequencing}, Epigenetics Sequencing {ChIP-Seq (Chromatin Immunoprecipitation
Sequencing), Methylation Sequencing}, Metagenomics Sequencing), By Product Type
(Sequencing Platforms, Consumables & Reagents {Sequencing Kits, Sample
Preparation Kits, Libraries}, Software & Services),By Application (Oncology
{Cancer Genome Sequencing, Liquid Biopsy, Biomarker Discovery}, Reproductive
Health, Infectious Diseases, Agricultural & Animal Research, Drug Discovery
& Development, Forensics), By End User (Academic & Research Institutes,
Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Diagnostic
Laboratories, Government Agencies)- Industry Trends and Forecast to 2033
Global Next-Generation Sequencing
(NGS) Market size was valued at USD 8427.6 million in 2024 and is expected to grow
at a CAGR of 16.2% during the forecast period of 2025 to 2033.
Global Next-Generation Sequencing (NGS) Market Overview
Next-Generation Sequencing (NGS)
is a powerful, high-throughput era that permits fast sequencing of DNA and RNA,
presenting specified genetic insights with more velocity and accuracy as
compared to conventional sequencing methods. It has converted genomics studies
via way of means of permitting large-scale research in oncology, infectious
diseases, personalised medicine, and genetic disorders. NGS allows programs
together with whole-genome sequencing, focused sequencing, transcriptome
analysis, and epigenetic research. Its cap potential to generate full-size
quantities of records in a cost-powerful way helps medical diagnostics, drug
development, and precision therapies. With non-stop advancements, NGS is
turning into more and more crucial in each study and medical practice.
Global Next-Generation Sequencing (NGS) Market Scope
|
Factors |
Description |
|
Years Considered |
·
Historical Period: 2020-2023 ·
Base Year: 2024 ·
Forecast Period: 2025-2033 |
|
Segments |
·
By Technology: Whole Genome Sequencing (WGS),
Whole Exome Sequencing (WES), Targeted Sequencing {Gene Panels, Custom
Targeted Sequencing}, RNA Sequencing {Transcriptome Sequencing, Single-Cell
RNA Sequencing}, Epigenetics Sequencing {ChIP-Seq (Chromatin Immunoprecipitation
Sequencing), Methylation Sequencing}, Metagenomics Sequencing ·
By Product Type: Sequencing Platforms,
Consumables & Reagents {Sequencing Kits, Sample Preparation Kits,
Libraries}, Software & Services ·
By Application: Oncology {Cancer Genome
Sequencing, Liquid Biopsy, Biomarker Discovery}, Reproductive Health,
Infectious Diseases, Agricultural & Animal Research, Drug Discovery &
Development, Forensics ·
By End User: Academic & Research
Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology
Companies, Diagnostic Laboratories, Government Agencies |
|
Countries Catered |
North America ·
United States ·
Canada ·
Mexico Europe ·
United Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest of Europe Asia Pacific ·
China ·
India ·
Japan ·
Australia ·
South Korea ·
Rest of Asia Pacific Latin America ·
Brazil ·
Argentina ·
Rest of Latin America Middle East
& Africa ·
Saudi Arabia ·
South Africa ·
Rest of MEA |
|
Key Companies |
·
Illumina ·
QIAGEN ·
Thermo Fisher Scientific,
Inc. ·
Oxford Nanopore Technologies ·
BGI |
|
Market Trends |
·
Increasing adoption of single-cell sequencing
for detailed cellular insights ·
Expanding clinical applications, including
liquid biopsy and non-invasive prenatal testing (NIPT) |
Global Next-Generation Sequencing (NGS) Market Dynamics
The dynamics of the
Next-Generation Sequencing (NGS) marketplace are formed via way of means of its
transformative position in genomics, diagnostics, and precision medicine. Key
drivers consist of the growing occurrence of most cancers and genetic disorders,
developing adoption of personalised medicine, and improvements in sequencing
technology which have appreciably decreased expenses at the same time as
enhancing accuracy and throughput. Additionally, authorities’ investment and
huge-scale genomic initiatives are fuelling studies and development, in
addition increasing NGS programs in oncology, infectious disorder monitoring,
pharmacogenomics, and agricultural genomics. An important fashion is the
combination of NGS with bioinformatics and synthetic intelligence, permitting
superior records analysis, interpretation, and real-time scientific
decision-making.
Opportunities lie in increasing
scientific adoption of NGS-primarily based totally diagnostic tests, developing
liquid biopsy programs, and its capability in reproductive fitness and
microbiome studies. However, the marketplace faces restraints consisting of
excessive device and preservation expenses, records interpretation
complexities, and regulatory demanding situations. Key demanding situations
consist of moral concerns, standardization issues, and restrained professional
specialists to address and examine huge genomic datasets. Overall, the NGS
marketplace is poised for robust growth, pushed via way of means of
improvements and increasing healthcare programs, however it calls for
addressing infrastructure, regulatory, and staff barriers for sustained adoption.
Global Next-Generation
Sequencing (NGS) Market Segment Analysis
The Next-Generation Sequencing
(NGS) marketplace is widely segmented primarily based totally on technology,
product type, application, and end user, highlighting its various packages
throughout studies, healthcare, and industry. By technology, Whole Genome
Sequencing (WGS) offers complete insights into genetic variations, even as
Whole Exome Sequencing (WES) makes a speciality of protein-coding regions,
making it cost-powerful for ailment studies. Targeted Sequencing, together with
gene panels and custom sequencing, is gaining recognition in scientific
diagnostics for its precision and affordability. RNA Sequencing, together with
transcriptome and single-mobileular RNA sequencing, is revolutionizing gene
expression studies, even as Epigenetics Sequencing which include ChIP-Seq and
methylation sequencing helps information of gene regulation. Metagenomics
Sequencing is important for microbiome and environmental studies.
By product type, the marketplace
consists of sequencing systems because the spine of genomic studies,
consumables and reagents which include sequencing kits, library guidance kits,
and reagents that make certain habitual revenue, and software program and
services, which can be important for bioinformatics, information analysis, and
cloud-primarily based totally genomic workflows. In phrases of application,
oncology dominates with most cancers genome sequencing, liquid biopsies, and
biomarker discovery, even as different packages consist of reproductive fitness
(preimplantation and prenatal trying out), infectious diseases (pathogen
detection and surveillance), agricultural and animal studies (crop development
and breeding), drug discovery and development, and forensics.
By end user, educational and
studies institutes lead adoption because of great genomic studies, even as
hospitals and clinics an increasing number of use NGS for diagnostics and
customized medicine. Pharmaceutical and biotechnology businesses observe NGS in
drug discovery, partner diagnostics, and scientific trials, even as diagnostic
laboratories make bigger scientific trying out services. Government businesses
additionally play a crucial position through investment large-scale sequencing
initiatives and enforcing public fitness initiatives. This complete
segmentation highlights NGS as a versatile, hastily developing area with
packages throughout precision medicine, agriculture, and public fitness.
Global Next-Generation
Sequencing (NGS) Market Regional Analysis
The Next-Generation Sequencing
(NGS) marketplace indicates robust local increase patterns, pushed through
studies investment, healthcare adoption, and biotechnology advancements. North
America dominates the marketplace, supported through superior healthcare
infrastructure, massive authorities investment for genomics projects, and the
presence of main gamers together with Illumina and Thermo Fisher Scientific.
Europe follows closely, with robust projects in precision medicine,
collaborative studies programs, and developing medical adoption of NGS for
oncology and uncommon sickness diagnostics. Asia-Pacific is the
fastest-developing region, fueled through growing investments in genomics
studies, increasing biotech hubs in China, Japan, South Korea, and India, and
growing use of NGS in infectious sickness surveillance and agricultural
studies. Latin America is witnessing regular increase with enhancing healthcare
get admission to and partnerships for low-priced sequencing solutions, even as
the Middle East & Africa are at a nascent degree however displaying
capacity via authorities-led genomic projects and collaborations with worldwide
studies institutions.
Global Next-Generation Sequencing (NGS) Market Key
Players
·
Illumina
·
F. Hoffman-La Roche Ltd.
·
QIAGEN
·
Thermo Fisher Scientific, Inc.
·
Bio-Rad Laboratories, Inc.
·
Oxford Nanopore Technologies
·
PierianDx
·
Genomatix GmbH
·
DNASTAR, Inc.
·
Perkin Elmer, Inc.
·
Eurofins GATC Biotech GmbH
·
BGI
Recent Developments
In April 2024, Merck
KGaA announced the launch of the industry’s first comprehensive and
validated genetic stability assay, marking a significant advancement in
biomanufacturing safety. The newly introduced Aptegra CHO Genetic Stability
Assay integrates whole genome sequencing with advanced bioinformatics, offering
a streamlined approach to genetic stability testing. This all-in-one solution
is designed to accelerate biosafety evaluations, thereby facilitating a faster
and more efficient transition from clinical development to commercial-scale
production for biopharmaceutical clients.
In January 2024, QIAGEN
announced a significant upgrade to its QIAGEN CLC Genomics Workbench Premium,
integrating LightSpeed technology to enhance support for next-generation
sequencing (NGS) in somatic cancer secondary analysis. This advanced software
accelerator enables the rapid conversion of raw sequencing data from FASTQ
files to interpretable genetic variant data in VCF format, delivering results
at exceptional speed and cost-efficiency.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
